Two-part vaccine regimen to fight Ebola may offer a year's protection
The trial, conducted by Matthew D. Snape of the University of Oxford and colleagues, enrolled healthy participants aged 18-50 years in Britain.
Mar 15, 2017, 15:57 PM IST
MVA-BN-Filo